Osiris Therapeutics announced that they won a DoD contract worth up to $224.7 million for developing their adult mesenchymal stem cell (MSC)-based therapeutic for treating acute radiation exposure. T… more →
The Regeneration Stationjrowley wrote 1 year ago: Osiris Therapeutics announced that they won a DoD contract worth up to $224.7 million for developing … more →